Literature DB >> 21470199

Special issue of BJP on respiratory pharmacology.

Richard A Bond, Domenico Spina.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21470199      PMCID: PMC3085863          DOI: 10.1111/j.1476-5381.2011.01239.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  15 in total

Review 1.  New perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.

Authors:  J K L Walker; R B Penn; N A Hanania; B F Dickey; R A Bond
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 2.  Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.

Authors:  Bart C Moulton; Allison D Fryer
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 3.  Cough: an unmet clinical need.

Authors:  Peter V Dicpinigaitis
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 4.  Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies.

Authors:  Ma'en Obeidat; Ian P Hall
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 5.  β(2) -adrenoceptor agonists: current and future direction.

Authors:  Mario Cazzola; Luigino Calzetta; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 6.  Cytokine/anti-cytokine therapy - novel treatments for asthma?

Authors:  Philip M Hansbro; Gerard E Kaiko; Paul S Foster
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 7.  Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease.

Authors:  Klaus F Rabe
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 8.  Glucocorticosteroids: current and future directions.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 9.  New horizons in the treatment of cystic fibrosis.

Authors:  A W Cuthbert
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

Review 10.  New perspectives for the treatment of pulmonary hypertension.

Authors:  Reshma S Baliga; Raymond J MacAllister; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

View more
  1 in total

1.  Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma.

Authors:  Manveen K Gupta; Kewal Asosingh; Mark Aronica; Suzy Comhair; Gaoyuan Cao; Serpil Erzurum; Reynold A Panettieri; Sathyamangla V Naga Prasad
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.